Goldman Sachs reinstated coverage of Waters (WAT) with a Buy rating and $375 price target representing 26% upside. The firm says the majority of the headwinds that impacted the company’s Biosciences and Diagnostic business in Q1 are one-time in nature. The share selloff following the Q1 report “sets an attractive baseline for entry,” the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAT: